Donald Berry
8PUBLICATIONS
103CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.Patrick Y Wen, Donald A Berry, Meredith B Buxton
|Aug 14, 2025
Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research.Donald A Berry
|Dec 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.Kathy S Albain, Christina Yau, Emanuel F Petricoin
|Oct 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.Javier Oesterheld, William Ferguson, Jacqueline M Kraveka
|Jul 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design.Kristine Broglio, Lale Kostakoglu, Carol Ward
|Sep 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.Kirit Singh, Kristen A Batich, Patrick Y Wen
Pageof 2
Frequent Collaborators
2 joint publications
Meredith Buxton
2 joint publications
Howard Colman
2 joint publications
Michael Weller
1 joint publications
Genevieve Bergendahl
1 joint publications
Randal K Wada
1 joint publications
Don E Eslin
1 joint publications
William Roberts
1 joint publications
Giselle L Saulnier Sholler
1 joint publications
Kirit Singh
1 joint publications
Charles M Perou
